Breaking Down the FDA’s CBD Regulatory Status

CSP and compliance lawyer Jonathan Havens discuss the current state and future of cannabidiol

CHICAGO —Cannabidiol (CBD) has become one of the hottest retail product categories in recent years. But how has the category fared during the coronavirus pandemic, and how has CBD’s regulatory status changed this year?

  • Click here to view Winsight Media’s cross-channel CBD website

On this episode of At Your Convenience, Jonathan Havens joins CSP Editor Brett Dworski to break down the state of the CBD industry and how retailers can maneuver its regulatory landscape. Havens—partner for Philadelphia-based law firm Saul Ewing Arnstein & Lehr—counsels on compliance, enforcement and transactional matters related to products regulated by the Dood and Drug Administration (FDA). He was a speaker at CSP’sCBD & Convenience Retail conference in October 2019. Listen as Havens and Dworski analyze how the coronavirus pandemic has affected the CBD industry, where the FDA stands on CBD, permissible claims for CBD and how potential changes in Washington could affect the CBD space.

At Your Convenience” brings industry experts and analysts together with CSP editors to discuss the latest in c-store news and trends. From mergers and acquisitions to foodservice and technology, the podcast delivers the story straight to listeners in short-format episodes, perfect for the morning commute or a quick break at the office.

Members help make our journalism possible. Become a CSP member today and unlock exclusive benefits, including unlimited access to all of our content. Sign up here.


Exclusive Content

Snacks & Candy

Convenience-Store Shoppers Are Sweet on Private-Label Candy

How 7-Eleven, Love’s are jumping on confection trends


How to Make the C-Store the Hero for Retail Media Success

Here’s what motivates consumers when it comes to in-store and digital advertising

Mergers & Acquisitions

Soft Landing Now, But If Anyone Is Happy, Please Stand Up to Be Seen

Addressing the economic elephants in the room and their impact on M&A


More from our partners